Tatva Chintan Pharma Quarterly Results for Trading Insights

TATVA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QSept 2025
Quarterly Results

Tatva Chintan Pharma Quarterly Results Key Highlights

  • Revenue of ₹125 Cr in Sept 2025 (+14.7% vs Mar 2025, +48.8% vs Sept 2024)
  • Net Profit of ₹10 Cr in Sept 2025 (+900.0% vs Mar 2025, +1100.0% vs Sept 2024)
  • EBITDA of ₹23 Cr in Sept 2025 (+130.0% vs Mar 2025)
  • Operating Margin of 18.0% in Sept 2025 (+10.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.24 in Sept 2025 (+863.6% vs Mar 2025)

Tatva Chintan Pharma Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 125 109 118 133 84 14.7% 48.8%
Net Profit (₹ Cr) 10 1 7 15 -1 - -
EBITDA (₹ Cr) 23 10 19 27 6 - -
EPS (₹) 4.24 0.44 2.84 6.49 -0.29 - -
Operating Margin (%) 18.0% 8.0% 15.0% 19.0% 7.0% - -

Tatva Chintan Pharma Share Price Trend Around Quarterly Results

Visualize Tatva Chintan Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Tatva Chintan Pharma

Additional stock information and data for TATVA

Tatva Chintan Pharma share price chart
TATVA P/E comparison
TATVA price range

Profitability Ratios

Profit Margin 8.0%
EBITDA Margin 18.4%
Operating Margin 18.0%
ROE (Annual) 5.4%

Balance Sheet Highlights

Total Assets ₹836 Cr
Total Equity ₹739 Cr
Current Assets ₹265 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹25 Cr
Investing Cash Flow ₹-65 Cr
Financing Cash Flow ₹17 Cr
Net Cash Flow ₹-24 Cr

Current Market Data

Current Price ₹1145.40
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 133
Jun 2025 118
Mar 2025 109
Sept 2025 125

Net Profit Trend (₹ Cr)

Dec 2025 15
Jun 2025 7
Mar 2025 1
Sept 2025 10

Operating Margin Trend (%)

Dec 2025 19.0%
Jun 2025 15.0%
Mar 2025 8.0%
Sept 2025 18.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Tatva Chintan Pharma quarterly results with other companies in Chemicals sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025 		₹129,622.71 Cr 1295.1 3,605 585 +11.9% - 16.2% 227.6
SRF
Sept 2025 		₹71,619.20 Cr 2396.0 3,560 388 -16.2% - 10.9% 182.9
Linde
Sept 2025 		₹62,227.63 Cr 7096.0 650 171 +7.4% - 26.3% 353.9
Coromandel Internat…
Sept 2025 		₹55,034.98 Cr 2010.9 9,771 793 +78.9% - 8.1% 73.6
Fertilisers & Chemi…
Sept 2025 		₹50,067.19 Cr 790.8 1,681 21 +48.8% - 1.2% 2471.1
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores